Treasurer Of The State Of North Carolina Iovance Biotherapeutics, Inc. Transaction History

Treasurer Of The State Of North Carolina

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 02, 2022	SELL	$6.38 - $18.33 $350,370 - $1.01 Million	-54,917 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$12.38 - $19.1 $10,869 - $16,769	878 Added 1.62%	54,917 $914,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $16,384 - $27,353	990 Added 1.87%	54,039 $1.03 Million
Q3 2021 Nov 03, 2021	BUY	$20.35 - $26.63 $51,058 - $66,814	2,509 Added 4.96%	53,049 $1.31 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $163 - $330	10 Added 0.02%	50,540 $1.32 Million
Q1 2021 May 03, 2021	SELL	$28.67 - $52.59 $3,727 - $6,836	-130 Reduced 0.26%	50,530 $1.6 Million
Q4 2020 Feb 02, 2021	BUY	$28.04 - $50.26 $3,364 - $6,031	120 Added 0.24%	50,660 $2.35 Million
Q3 2020 Nov 04, 2020	BUY	$27.75 - $36.3 $24,420 - $31,943	880 Added 1.77%	50,540 $1.66 Million
Q2 2020 Aug 07, 2020	BUY	$27.21 - $41.0 $1.35 Million - $2.04 Million	49,660 New	49,660 $1.36 Million

342

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $562M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.